265 related articles for article (PubMed ID: 18289048)
1. Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cell.
Bruserud Ø; Stapnes C; Ersvaer E; Gjertsen BT; Ryningen A
Curr Pharm Biotechnol; 2007 Dec; 8(6):388-400. PubMed ID: 18289048
[TBL] [Abstract][Full Text] [Related]
2. Histone Deacetylase Inhibitors as Anticancer Drugs.
Eckschlager T; Plch J; Stiborova M; Hrabeta J
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671573
[TBL] [Abstract][Full Text] [Related]
3. Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond.
Konstantinopoulos PA; Karamouzis MV; Papavassiliou AG
Expert Opin Investig Drugs; 2007 May; 16(5):569-71. PubMed ID: 17461732
[TBL] [Abstract][Full Text] [Related]
4. Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.
Hanikoglu A; Hanikoglu F; Ozben T
Curr Protein Pept Sci; 2018; 19(3):333-340. PubMed ID: 28059044
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors in cancer treatment.
Vigushin DM; Coombes RC
Anticancer Drugs; 2002 Jan; 13(1):1-13. PubMed ID: 11914636
[TBL] [Abstract][Full Text] [Related]
6. HDAC inhibitors for the treatment of cancer.
Secrist JP; Zhou X; Richon VM
Curr Opin Investig Drugs; 2003 Dec; 4(12):1422-7. PubMed ID: 14763127
[TBL] [Abstract][Full Text] [Related]
7. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer.
Johnstone RW
Nat Rev Drug Discov; 2002 Apr; 1(4):287-99. PubMed ID: 12120280
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis.
Shankar S; Srivastava RK
Adv Exp Med Biol; 2008; 615():261-98. PubMed ID: 18437899
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors in cancer therapy.
Rasheed WK; Johnstone RW; Prince HM
Expert Opin Investig Drugs; 2007 May; 16(5):659-78. PubMed ID: 17461739
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.
Marks PA; Richon VM; Rifkind RA
J Natl Cancer Inst; 2000 Aug; 92(15):1210-6. PubMed ID: 10922406
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
12. Targeting histone deacetylases: development of vorinostat for the treatment of cancer.
Richon VM
Epigenomics; 2010 Jun; 2(3):457-65. PubMed ID: 22121904
[TBL] [Abstract][Full Text] [Related]
13. Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML.
Bruserud Ø; Stapnes C; Tronstad KJ; Ryningen A; Anensen N; Gjertsen BT
Expert Opin Ther Targets; 2006 Feb; 10(1):51-68. PubMed ID: 16441228
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors in cancer therapy. A review.
Hrabeta J; Stiborova M; Adam V; Kizek R; Eckschlager T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):161-9. PubMed ID: 24263215
[TBL] [Abstract][Full Text] [Related]
16. Role of histone deacetylase inhibitors in the treatment of cancer (Review).
Mei S; Ho AD; Mahlknecht U
Int J Oncol; 2004 Dec; 25(6):1509-19. PubMed ID: 15547685
[TBL] [Abstract][Full Text] [Related]
17. The clinical development of histone deacetylase inhibitors as targeted anticancer drugs.
Marks PA
Expert Opin Investig Drugs; 2010 Sep; 19(9):1049-66. PubMed ID: 20687783
[TBL] [Abstract][Full Text] [Related]
18. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
Li Y; Seto E
Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
[TBL] [Abstract][Full Text] [Related]
19. Anticancer activities of histone deacetylase inhibitors.
Bolden JE; Peart MJ; Johnstone RW
Nat Rev Drug Discov; 2006 Sep; 5(9):769-84. PubMed ID: 16955068
[TBL] [Abstract][Full Text] [Related]
20. Role of histone deacetylases and their inhibitors in cancer biology and treatment.
Beumer JH; Tawbi H
Curr Clin Pharmacol; 2010 Aug; 5(3):196-208. PubMed ID: 20406169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
